These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3131969)
1. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I. Bachmann KA; Yang C; Jahn D; Schwartz J Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969 [TBL] [Abstract][Full Text] [Related]
2. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism. Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290 [TBL] [Abstract][Full Text] [Related]
3. The use of single-sample clearance estimates to probe hepatic drug metabolism in rats. IV. A model for possible application to phenotyping xenobiotic influences on human drug metabolism. Bachmann KA Xenobiotica; 1989 Dec; 19(12):1449-59. PubMed ID: 2618092 [TBL] [Abstract][Full Text] [Related]
4. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II. Bachmann KA; Jahn D; Yang C; Schwartz J Xenobiotica; 1988 Feb; 18(2):161-7. PubMed ID: 3131970 [TBL] [Abstract][Full Text] [Related]
5. Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure. Bachmann K Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):167-70. PubMed ID: 3710629 [TBL] [Abstract][Full Text] [Related]
6. Exercise training does not alter cytochrome P-450 content and microsomal metabolism. Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432 [TBL] [Abstract][Full Text] [Related]
7. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum. Shibata Y; Takahashi H; Ishii Y Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592 [TBL] [Abstract][Full Text] [Related]
9. Single sample estimate of ethosuximide clearance. Bachmann K; Schwartz J; Sullivan T; Jauregui L Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):546-50. PubMed ID: 3781674 [TBL] [Abstract][Full Text] [Related]
10. The effects of cobalt chloride, SKF-525A, and N-(3,5-dichlorophenyl)succinimide on in vivo hepatic mixed function oxidase activity as determined by single-sample plasma clearances. Bachmann KA; Madhira MS; Rankin GO Xenobiotica; 1992 Jan; 22(1):27-31. PubMed ID: 1615705 [TBL] [Abstract][Full Text] [Related]
11. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state. Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489 [TBL] [Abstract][Full Text] [Related]
12. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of phenobarbitone on human hepatic drug metabolism. Bachmann KA; Nunlee M; Martin M; Jaregui L Xenobiotica; 1991 Oct; 21(10):1385-92. PubMed ID: 1796615 [TBL] [Abstract][Full Text] [Related]
13. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance. Surma MJ; Frieske I; Jencz K; Kuźmierek J Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475 [TBL] [Abstract][Full Text] [Related]
14. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample. Loft S; Nielsen AJ; Borg BE; Poulsen HE Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365 [TBL] [Abstract][Full Text] [Related]
15. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. Rane A; Wilkinson GR; Shand DG J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445 [TBL] [Abstract][Full Text] [Related]
16. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819 [TBL] [Abstract][Full Text] [Related]
17. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application. Wong H; Grossman SJ; Bai SA; Diamond S; Wright MR; Grace JE; Qian M; He K; Yeleswaram K; Christ DD Drug Metab Dispos; 2004 Dec; 32(12):1359-69. PubMed ID: 15333515 [TBL] [Abstract][Full Text] [Related]
18. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED; Walker A; Hoffer C; Sheffels P Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene. Groen K; Breimer DD; van Bezooijen CF Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725 [TBL] [Abstract][Full Text] [Related]
20. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans. Abernethy DR; Egan JM; Dickinson TH; Carrum G J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]